References - Therapeutic Strategies in Cancer Biology and Pathology - page 234

Muinos-Gimeno, M., Espinosa-Parrilla, Y., Guidi, M., Kagerbauer, B., Sipilae, T., Maron, E.,
et al., 2011. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associ-
ated with panic disorder and regulate several anxiety candidate genes and related path-
ways. Biol. Psychol. 69, 526-533.
Muley, A., Majumder, S., Kolluru, G.K., Parkinson, S., Viola, H., Hool, L., et al., 2010. Secreted
Frizzled-related protein 4 an angiogenesis inhibitor. Am. J. Pathol. 176, 1505-1516.
Murillo, M.M., del Castillo, G., Sanchez, A., Fernandez, M., Fabregat, I., 2005. Involvement
of EGF receptor and c-Src in the survival signals induced by TGF-beta 1 in hepatocytes.
Oncogene, 244580-244587.
Murray, M.J., Halsall, D.J., Hook, C.E., Williams, D.M., Nicholson, J.C., Coleman, N., 2011.
Identification of microRNAs from the miR-371 similar to 373 and miR-302 clusters as
potential serum biomarkers of malignant germ cell tumors. Am. J. Clin. Pathol. 135,
119-125.
Nadal, A., Ropero, A.B., Laribi, O., Maillet, M., Fuentes, E., Soria, B., 2000. Nongenomic
actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unre-
lated to estrogen receptor α and estrogen receptor β. Proc. Natl. Acad. Sci. U.S.A. 97,
11603-11608.
Nagai, K., Doi, R., Katagiri, F., Ito, T., Kida, A., Koizumi, M., et al., 2009. Prognostic value of
metastin expression in human pancreatic cancer. J. Exp. Clin. Cancer Res. 28, 9.
Nagai, M.A., Gerhard, R., Fregnani, J.H.T.G., Nonogaki, S., Rierger, R.B., Netto, M.M.,
et al., 2011. Prognostic value of NDRG1 and SPARC protein expression in breast cancer
patients. Breast Cancer Res. Treat. 126, 1-14.
Nagaraja, A.K., Creighton, C.J., Yu, Z., Zhu, H., Gunaratne, P.H., Reid, J.G., et al., 2010. A
link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol. Endocrinol.
24, 447-463.
Nagji, A.S., Liu, Y., Stelow, E.B., Stukenborg, G.J., Jones, D.R., 2010. BRMS1 transcriptional
repression correlates with CpG island methylation and advanced pathological stage in
non-small cell lung cancer. J. Pathol. 221, 229-236.
Nagy, N., Brenner, C., Markadieu, N., Chaboteaux, C., Camby, I., Schafer, B.W., et al., 2001.
S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma
migration. Lab. Invest. 81, 599-612.
Naidoo, K., Jones, R., Dmitrovic, B., Wijesuriya, N., Kocher, H., Hart, I.R., et al., 2012.
Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and
lymph node metastases. J. Pathol. 226, 756-763.
Nakamura, Y., Oshima, K., Naoi, Y., Nakayama, T., Kim, S.J., Shimazu, K., et al., 2012. 14-
3-3 sigma expression is associated with poor pathological complete response to neoad-
juvant chemotherapy in human breast cancers. Breast Cancer Res. Treat. 134, 229-236.
Nakazawa, Y., Kamijo, T., Koike, K., Noda, T., 2003. ARF tumour suppressor induces mito-
chondria dependent apoptosis by modudlation of mitochondrial Bcl-2 family proteins. J.
Biol. Chem. 278, 27888-27895.
Nalls, D., Tang, S.N., Rodova, M., Srivastava, R.K., Shankar, S., 2011. Targeting epigenetic
regulation of miR-34a for treatment of pancreatic Cancer by inhibition of pancreatic can-
cer stem cells. Plos ONE 6, e24099.
Nambotin, S.B., Lefrancois, L., Sainsily, X., Berthillon, P., Kim, M., Wands, J.R., et al., 2011.
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular
carcinoma. J. Hepatol. 54, 288-299.
Nath-Sain, S., Marignani, P.A., 2009. LKB1 catalytic activity contributes to estrogen receptor
alpha signalling. Mol. Biol. Cell. 20, 2785-2795.
Neal, C.L., Yu, D., 2010. 14-3-3 zeta as a prognostic marker and therapeutic target for cancer.
Expert Opin. Ther. Targets 14, 1343-1354.